M. Sánchez-Martín is currently an Assistant Professor in the Department of Medicine at the University of Salamanca (USAL) and the Head of the Transgenic Facility at USAL and the Institute of Biomedical Research of Salamanca (IBSAL). Dr. Sánchez-Martín completed his undergraduate studies in Biochemistry in 1994, after which he began his predoctoral training focused on malignant blood diseases across three different centers:
- The Hematology Service of the Hospital Clínico Universitario of Salamanca, where he focused on molecular cytogenetics in leukemias.
- The Institute of Microbiology and Biochemistry, where his work centered on modeling leukemia disease in mice.
- The Cancer Research Center, where he studied the role of SNAI2 in neoplastic diseases arising from mesenchymal cells (leukemias, lymphomas, and sarcomas).
Following his predoctoral training, he was awarded a Ph.D. with an "Outstanding Cum Laude" qualification and the Extraordinary Award for his thesis work. As a result of this training, several scientific contributions were published in Q1 scientific journals. He then secured a postdoctoral fellowship from the Spanish Association for Cancer (AECC) and a postdoctoral research position through the Spanish "Ramón y Cajal" Research Program. He attained the Assistant Professor position at USAL in 2010 and the Lecturer position in 2020.
During his pre- and postdoctoral career, he conducted research stays at various national scientific centers, including INIA, CNB, INSTI
M. Sánchez-Martín is currently an Assistant Professor in the Department of Medicine at the University of Salamanca (USAL) and the Head of the Transgenic Facility at USAL and the Institute of Biomedical Research of Salamanca (IBSAL). Dr. Sánchez-Martín completed his undergraduate studies in Biochemistry in 1994, after which he began his predoctoral training focused on malignant blood diseases across three different centers:
- The Hematology Service of the Hospital Clínico Universitario of Salamanca, where he focused on molecular cytogenetics in leukemias.
- The Institute of Microbiology and Biochemistry, where his work centered on modeling leukemia disease in mice.
- The Cancer Research Center, where he studied the role of SNAI2 in neoplastic diseases arising from mesenchymal cells (leukemias, lymphomas, and sarcomas).
Following his predoctoral training, he was awarded a Ph.D. with an "Outstanding Cum Laude" qualification and the Extraordinary Award for his thesis work. As a result of this training, several scientific contributions were published in Q1 scientific journals. He then secured a postdoctoral fellowship from the Spanish Association for Cancer (AECC) and a postdoctoral research position through the Spanish "Ramón y Cajal" Research Program. He attained the Assistant Professor position at USAL in 2010 and the Lecturer position in 2020.
During his pre- and postdoctoral career, he conducted research stays at various national scientific centers, including INIA, CNB, INSTI